Successful factorial design for the optimization of methylprednisolone encapsulation in biodegradable nanoparticles

References

• Craig, CR. (2003). Modern pharmacology with clinical applications.
   Google Scholar
• Morand EF. (2000). Corticosteroids in the treatment of rheumatologic diseases. Curr Opin Rheumatol, 12:171–177.
   PubMed Web of Science ®Google Scholar
• Habib GS, Saliba W, Nashashibi M. (2010). Local effects of intra-articular corticosteroids. Clin Rheumatol, 29:347–356.
   PubMed Web of Science ®Google Scholar
• Sobande PO, Kercsmar CM. (2008). Inhaled corticosteroids in asthma management. Respir Care, 53:625– 33; discussion 633.
   PubMed Web of Science ®Google Scholar
• Cunningham ET Jr, Wender JD. (2010). Practical approach to the use of corticosteroids in patients with uveitis. Can J Ophthalmol, 45:352–358.
   PubMed Web of Science ®Google Scholar
• Lobo AM, Sobrin L, Papaliodis GN. (2010). Drug delivery options for the treatment of ocular inflammation. Semin Ophthalmol, 25:283–288.
   PubMed Web of Science ®Google Scholar
• Hogewind BF, Zijlstra C, Klevering BJ, Hoyng CB. (2008). Intravitreal triamcinolone for the treatment of refractory macular edema in idiopathic intermediate or posterior uveitis. Eur J Ophthalmol, 18:429–434.
   PubMed Web of Science ®Google Scholar
• Owczarek J, Jasinska M, Orszulak-Michalak D. (2005). Drug-induced myopathies. An overview of the possible mechanisms. Pharmacol Rep, 57:23–34.
   PubMed Web of Science ®Google Scholar
• Guillot B. (2002). Adverse skin reactions to inhaled corticosteroids. Expert Opin Drug Saf, 1:325–329.
   PubMedGoogle Scholar
• McDonough AK, Curtis JR, Saag KG. (2008). The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol, 20:131–137.
   PubMed Web of Science ®Google Scholar
• Marcato PD, Durán N. (2008). New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol, 8:2216–2229.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Borm PJ. (2008). Drug delivery and nano­particles:applications and hazards. Int J Nanomedicine, 3:133–149.
   PubMed Web of Science ®Google Scholar
• Mohamed F, van der Walle CF. (2008). Engineering biodegradable polyester particles with specific drug targeting and drug release properties. J Pharm Sci, 97:71–87.
   PubMed Web of Science ®Google Scholar
• Shive MS, Anderson JM. (1997). Biodegradation and bio­compatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev, 28:5–24.
   PubMed Web of Science ®Google Scholar
• Athanasiou KA, Niederauer GG, Agrawal CM. (1996). Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials, 17:93–102.
   PubMed Web of Science ®Google Scholar
• Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. (2004). Solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci, 93:1804–1814.
   PubMed Web of Science ®Google Scholar
• Gómez-Gaete C, Fattal E, Silva L, Besnard M, Tsapis N. (2008). Dexamethasone acetate encapsulation into Trojan particles. J Control Release, 128:41–49.
   PubMed Web of Science ®Google Scholar
• Boddu SH, Jwala J, Vaishya R, Earla R, Karla PK, Pal D et al. (2010). Novel nanoparticulate gel formulations of steroids for the treatment of macular edema. J Ocul Pharmacol Ther, 26:37–48.
   PubMed Web of Science ®Google Scholar
• Gómez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E. (2007). Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm, 331:153–159.
   PubMed Web of Science ®Google Scholar
• Vitorino C, Carvalho FA, Almeida AJ, Sousa JJ, Pais AA. (2011). The size of solid lipid nanoparticles: an interpretation from experimental design. Colloids Surf B Biointerfaces, 84:117–130.
   PubMed Web of Science ®Google Scholar
• Carbone C, Tomasello B, Ruozi B, Renis M, Puglisi G. (2012). Preparation and optimization of PIT solid lipid nanoparticles via statistical factorial design. Eur J Med Chem, 49C:110–117.
   Google Scholar
• Li L, Zhao X, Yang C, Hu H, Qiao M, Chen D. (2011). Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology. Drug Dev Ind Pharm, 37:1170–1180.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H et al. (2009). The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Colloids Surf B Biointerfaces, 74:340–349.
   PubMed Web of Science ®Google Scholar
• Wischke C, Schwendeman SP. (2008). Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm, 364:298–327.
   PubMed Web of Science ®Google Scholar
• McCarron PA, Donnelly RF, Marouf W. (2006). Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emul­sification steps as part of the salting-out procedure. J Micro­encapsul, 23:480–498.
   PubMed Web of Science ®Google Scholar
• Jeyanthi R, Mehta RC, Thanoo BC, DeLuca PP. (1997). Effect of processing parameters on the properties of peptide-containing PLGA microspheres. J Microencapsul, 14:163–174.
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. (2005). PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm, 290:137–144.
   PubMed Web of Science ®Google Scholar
• Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. (1997). Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Contr Release 43:197–212.
   Web of Science ®Google Scholar
• Lemoine D, Préat V. (1998). Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J Control Release, 54:15–27.
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. (2003). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55:329–347.
   PubMed Web of Science ®Google Scholar
• Leong TS, Wooster TJ, Kentish SE, Ashokkumar M. (2009). Minimising oil droplet size using ultrasonic emulsification. Ultrason Sonochem, 16:721–727.
   PubMed Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm, 336:367–375.
   PubMed Web of Science ®Google Scholar
• Moffat A, et al. (2004). Clarke’s analysis of drugs and poisons.
   Google Scholar
• Feng S, Huang G. (2001). Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 71:53–69.
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. (2007). Nanosizing–oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev, 59:631–644.
   PubMed Web of Science ®Google Scholar
• Clas SD, Dalton CR, Hancock BC. (1999). Differential scanning calorimetry: applications in drug development. Pharm Sci Technol Today, 2:311–320.
   PubMedGoogle Scholar
• Guillory JK. (1967). Heats of transition of methylprednisolone and sulfathiazole by a differential thermal analysis method. J Pharm Sci, 56:72–76.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 86:33–48.
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 70:1–20.
   PubMed Web of Science ®Google Scholar